Phase 1b, Randomized, Single-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MP-376 Inhalation Solution Administered for 5 Days to Chronic Bronchitis Patients.
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Levofloxacin (Primary)
- Indications Bacterial infections; Chronic bronchitis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Mpex Pharmaceuticals
- 22 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Dec 2008 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 30 Sep 2008 New trial record.